On August 18, PA GoodDoctor (01833.HK) unveiled a half-year scorecard where profit expansion dramatically outpaced revenue growth—total revenue reached RMB 2.484 billion, while net profit attributable to shareholders hit RMB 219 million, a 63.5% year-on-year surge. Adjusted net profit came in at RMB 227 million, climbing 37.7%. The same day, a board announcement confirmed the appointment of Zhu Yougang as the new Chairman. Having joined the Ping An Group in 1994, this 32-year company veteran now wears two hats simultaneously: Party Secretary, Chairman, and CEO of Ping An Health Insurance, alongside his roles as Party Secretary and Chairman of Peking University Medical Management. This dual leadership is poised to unlock highly efficient ecosystem synergies and deepen the construction of PA GoodDoctor's managed care closed-loop.

Why profit growth far outpaces revenue—structural optimization is the underlying engine

Revenue of RMB 2.484 billion paired with a profit jump of over 60%—this divergence is a direct reflection of PA GoodDoctor's continuously improving business structure. Breaking down the revenue mix, the insurance channel (F-side) contributed RMB 1.584 billion, still anchoring the top line. The enterprise health management (B-side) segment generated RMB 714 million, up 65.1% year-on-year, lifting its share of total revenue to 28.7%, a rise of 11.5 percentage points. Paying corporate clients surpassed 7,700, a year-on-year growth of over 73%. This signals that the B-side is rapidly transitioning from bespoke project-based offerings to standardized products, with a solid foundation for scale expansion now firmly in place.

More critical is AI's transformative effect on cost structure. During the reporting period, AI physicians served over 9.7 million users, accurately diagnosing more than 11,300 diseases with an auxiliary diagnostic accuracy rate approaching 96%. AI-driven business contributed approximately 4.6% of gross profit. When AI handles high-frequency, standardized diagnostic needs while human doctors focus on complex case reviews, marginal service costs decline as scale expands—this is the core competitive moat distinguishing PA GoodDoctor from traditional internet healthcare platforms.

Zhu Yougang's dual role is the key to deciphering 'two synergies'

On the surface, this is a routine board reshuffle. In reality, it is a pivotal move on PA GoodDoctor's strategic chessboard, one that simultaneously integrates the 'online + offline' and 'medical + insurance' tracks. Zhu's uniqueness lies in his grip on both ends: Ping An Health Insurance represents the payer side, while Peking University Medical Management represents the provider side. In the classic managed care model, deep alignment between payer and provider is the prerequisite for a closed loop. With Zhu commanding both ends, PA GoodDoctor's online service capabilities, Peking University Medical's offline physical resources, and Ping An Health Insurance's payment power can be efficiently coupled under a single coordinator. The board has explicitly affirmed its confidence in the medical-insurance synergy opportunity, vowing to build an integrated online-offline healthcare closed loop.

The first synergy: online-offline integration, weaving online strengths and Peking University Medical's offline assets into one cohesive fabric. PA GoodDoctor boasts 400 million registered users, an internal and external physician team of approximately 50,000, and over 3,700 contracted experts—including 9 academicians or national TCM masters and more than 820 hospital directors and discipline leaders. It partners with 3,216 Ping An-selected hospitals, including 1,732 tertiary-A facilities, and has built over 500 'Ping An Circle' three-kilometer service networks—this is the online traffic and supply backbone. Peking University Medical Group operates 11 healthcare institutions, including Peking University International Hospital, with over 10,000 beds in total, covering the entire spectrum from prevention, screening, diagnosis, treatment to rehabilitation management—this is the offline physical resource base. With Zhu concurrently chairing Peking University Medical Management, PA GoodDoctor's online platform and Peking University Medical's offline entities are no longer loosely affiliated partners but 'two faces of the same closed loop.'

The second synergy: medical-insurance integration, enabling bidirectional empowerment between healthcare services and health insurance operations. The Ping An Group serves over 200 million individual clients, with the largest health insurance premium scale in the country. As of the reporting period, customers entitled to Ping An home-based care rights saw a 9.7-fold increase in average first-year premium per new life insurance policy, while eligible home-care service users surpassed 310,000 across 140 cities. Zhu's simultaneous leadership of Ping An Health Insurance means the barriers between 'medical service supply' and 'insurance payment capacity' are being dismantled at the institutional level. Healthcare services provide insurers with differentiated product power for customer acquisition and retention, while insurance payments offer healthcare services a stable, scalable flow of clients—this virtuous cycle of mutual empowerment is the core formula for a managed care model with Chinese characteristics.

Both synergies converge on a single goal: deeply cultivating a distinctive Chinese managed care model to establish a durable competitive edge. Over the past year, the company has undergone a series of board adjustments. As the flagship of the Ping An Group's medical and elderly care ecosystem, PA GoodDoctor's strategic positioning remains unchanged and will not change. Zhu's appointment is not a shift in direction but an acceleration of execution.

Assessing PA GoodDoctor's valuation

As of the August 19 close, PA GoodDoctor had a market capitalization of approximately HK$15.5 billion, with a trailing P/E of about 29 times and a price-to-book ratio of 1.34 times. Compared with Hong Kong-listed peers—Hygeia Healthcare (06078) trades at roughly 33 times P/E, while Gushengtang (02273) is at about 15 times—PA GoodDoctor's valuation sits in the industry's mid-range. Looking back at full-year 2025, the company's net profit attributable to shareholders reached RMB 380 million, up 366.1% year-on-year. In H1 2026, profit growth has remained at elevated levels; extrapolating from the first-half net profit of RMB 219 million and the 63.5% growth rate, full-year profit is projected to exceed RMB 500 million, corresponding to a forward P/E of around 30 times. For a healthcare platform simultaneously possessing AI-driven cost reduction elasticity, high-growth enterprise health management (B-side revenue up 65.1%), and deepening medical-insurance synergies—three growth trajectories—the door to valuation recovery is swinging open. As medical-insurance integration and online-offline healthcare resource convergence deepen, PA GoodDoctor is accelerating the value realization of a Chinese-style managed care model with a clearer profitability path and a more solid business foundation. Going forward, its core flagship role within the Ping An Group's medical and elderly care ecosystem will become increasingly pronounced.